SEC Form D private-offering filing

X1 Biotech Inc.

Name: X1 Biotech Inc. - new SEC Form D private-offering filing, Needham, MA
Published: 2026-06-15

A new SEC Form D private-offering notice from Needham, MA, a $2,000,000 filer-stated offering target in Biotech. The source filing is one click away.

X1 Biotech Inc. site↗ Verified via SEC Form D

Developing X101, a repurposed small molecule RUNX1 inhibitor for CADASIL, with potential expansion into other vascular diseases.

Filed 2026-06-15Filed to raise $2,000,000First money in 2026-05-20Raised so far $40,000HQ (as filed) Needham, MASector Biotech ✓Stage (inferred) SeedCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified x1biotech.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.